A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
Public ClinicalTrials.gov record NCT07357740. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study to Compare Two Presentations of CagriSema in Participants With Type 2 Diabetes
Study identification
- NCT ID
- NCT07357740
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- CagriSema Drug
- Placebo CagriSema Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 26, 2026
- Primary completion
- Aug 24, 2027
- Completion
- Oct 12, 2027
- Last update posted
- Mar 29, 2026
2026 – 2027
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Clinical Research | Little Rock | Arkansas | 72205 | — |
| Paradigm Clinical Research | San Diego | California | 92108 | — |
| Encompass Clinical Research_Spring Valley | Spring Valley | California | 91978 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Future Medical Research | Longwood | Florida | 32750 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Clinical Site Partners Kendall Flourish Research | Miami | Florida | 33186 | — |
| West Orange Endocrinology | Ocoee | Florida | 34761 | — |
| Center for Diab,Obes & Metab | Pembroke Pines | Florida | 33024 | — |
| American Research Centers of Florida | Pembroke Pines | Florida | 33027 | — |
| Hope Clin Res & Wellness | Conyers | Georgia | 30094 | — |
| Elevate Clinical Research | Gurnee | Illinois | 60031 | — |
| Accellacare of Duly Oak Lawn | Oak Lawn | Illinois | 60453 | — |
| KDCILM, LLC & Accellacare US, Inc. | Wilmington | North Carolina | 28401 | — |
| Advanced Medical Research - Maumee | Maumee | Ohio | 43537 | — |
| Clinical Res Collaborative | Cumberland | Rhode Island | 02864 | — |
| Clinical Research Associates | Nashville | Tennessee | 37203 | — |
| The Endocrine Center | Houston | Texas | 77079 | — |
| Radiance Clinical Research | Lampasas | Texas | 76550 | — |
| Quality Research Inc | San Antonio | Texas | 78209 | — |
| Medrasa Clinical Research | Sherman | Texas | 75092 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07357740, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07357740 live on ClinicalTrials.gov.